Detalles de la búsqueda
1.
Triple-Negative Breast Cancer EVs Modulate Growth and Migration of Normal Epithelial Lung Cells.
Int J Mol Sci
; 25(11)2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38892050
2.
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports.
Oncology
; 94 Suppl 1: 34-44, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30041178
3.
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.
Breast Cancer Res Treat
; 163(3): 587-594, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28353061
4.
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice.
BMC Cancer
; 16(1): 709, 2016 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27590845
5.
Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study.
Future Oncol
; 11(2): 219-24, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25078333
6.
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
Breast J
; 26(9): 1857-1859, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32436244
7.
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey.
Future Oncol
; 10(1): 69-78, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24328410
8.
Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial.
Breast
; 75: 103725, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615483
9.
Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical exploration.
Ann Surg Oncol
; 17(8): 2092-101, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20224860
10.
Acceptance and adherence of oral endocrine therapy in women with metastatic breast cancer: exacampania group study.
Breast J
; 21(3): 326-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25790292
11.
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting.
Oncotarget
; 11(22): 2083-2091, 2020 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32547706
12.
Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802).
Clin Colorectal Cancer
; 19(2): 109-115, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32089455
13.
Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience.
Tumori
; 106(4): 301-305, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31847742
14.
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies.
Breast Care (Basel)
; 15(1): 30-37, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32231495
15.
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer.
ESMO Open
; 4(4): e000519, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31555481
16.
BAG3 is a novel serum biomarker for pancreatic adenocarcinomas.
Am J Gastroenterol
; 108(7): 1178-80, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23821002
17.
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety.
Mol Clin Oncol
; 9(3): 255-263, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30155246
18.
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(94): 36720-36721, 2018 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30613355
19.
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(77): 34639-34640, 2018 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30349655
20.
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(61): 31877-31887, 2018 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30159129